Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
385.00    -2.00 (-0.52%)
Bid:
382.50
Ask:
385.00
Spread: 2.50 (0.654%)
Market Cap: £1.74b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

19 Dec 2007 14:25

HG Capital Trust PLC19 December 2007 The following is the text of a press release issued by HgCapital, which managesthe investment portfolio of HgCapital Trust plc alongside those of otherinstitutional clients. The Trust, which is a listed investment trust givinginvestors the opportunity to participate in all of HgCapital's investments, willinvest approximately €16.7million (£12m) in Casa Reha. HgCapital acquires Casa Reha from Advent International London, 19th December 2007: HgCapital, the European sector-focused privateequity investor, has acquired Casa Reha, one of the leading German privatenursing home groups. The transaction is subject to regulatory approval. Thecompany has been acquired from Advent International and management, both ofwhich are re-investing in the business. The value of the transaction wasundisclosed. Casa Reha, founded in 1995 by Covenant Care International is headquartered inOberursel, Germany. The first nursing home was opened in 1996. Today, Casa Rehais the country's fifth largest nursing home operator, with a nationwideportfolio of 48 homes providing around 7,000 beds. Contacts: HgCapitalPhilipp Schwalber Tel: +44 (0)20 7089 7888 Hering-Schuppener (German Press)Georg Jakobs/Dennis Bader Tel: +49 (69) 92187476 Maitland (UK Press)Peter Ogden Tel: +44 (0)20 7379 5151 Advent InternationalClaudia Werth Tel: +49 (69) 92037 114 About HgCapitalHgCapital is a private-equity investor in the European mid-market. We focus oninvestments with an enterprise value in the range of €75-750 million. Ourbusiness model combines sector specialisation with dedicated, pro-active supportto our portfolio companies as well as the corresponding management expertiseacross all phases of the investment process. HgCapital manages more than €2.7billion for some of the world's leading institutional and private investors. Ourgoal is to achieve outstanding results for our investors, management team andintermediaries. Further information on HgCapital can be found atwww.hgcapital.com. HgCapital's recent transactions in the healthcare sector include: • May 2007: sale of DocMorris to Celesio • July 2006: sale of Castlebeck to Castle Holdings Limited for £255m • June 2006: IPO of ClinPhone - market capitalisation of £94 million • June 2006: Sale of Pharma Bio-Research BV (PBR) to PRA International for £58 million • April 2006: £322 million MBO of Paragon Healthcare • September 2005: Sale of Tunstall for £220 million About Advent InternationalFounded in 1984, Advent International is one of the world's leading globalprivate equity firms, with offices in 15 countries on four continents. A drivingforce in international private equity for more than two decades, Advent hasbuilt an unparalleled global platform of over 100 investment professionalsacross Western and Central Europe, North America, Latin America and Asia. Thefirm focuses on cross-border, strategic restructuring and growth opportunitiesin five core sectors, employing a highly focused ownership approach to driveearnings improvements in portfolio companies. Since inception, Advent has raised£6 billion in private equity capital and completed more than 200 buyout andprivate equity transactions valued at over £15 billion in 35 countries. For moreinformation, visit www.adventinternational.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 20229:45 amRNSTotal Voting Rights
31st Mar 20225:18 pmRNSIssue of Equity
30th Mar 20222:00 pmRNSHg announces investment in IFS and WorkWave
29th Mar 20225:33 pmRNSIssue of Equity
23rd Mar 20225:29 pmRNSIssue of Equity
7th Mar 20227:00 amRNSAnnual Financial Report
7th Mar 20227:00 amRNSAnnual Results for the year ended 31 December 2021
24th Jan 20227:00 amRNSHg announces investment in Waystone Group
21st Jan 20227:00 amRNSHg announces additional investment into Lyniate
5th Jan 202212:00 pmRNSHg announces investment in ProcessMAP Corporation
4th Jan 20227:00 amRNSTotal Voting Rights
31st Dec 20211:14 pmRNSIssue of Equity
29th Dec 20215:36 pmRNSIssue of Equity
23rd Dec 20215:09 pmRNSIssue of Equity
22nd Dec 20215:18 pmRNSIssue of Equity
21st Dec 20215:49 pmRNSIssue of Equity
17th Dec 20216:16 pmRNSIssue of Equity
16th Dec 20216:12 pmRNSIssue of Equity
14th Dec 202110:22 amRNSEdison issues update on HgCapital Trust (HGT)
13th Dec 20215:41 pmRNSIssue of Equity
10th Dec 20212:39 pmRNSFonds Finanz secures investment from Hg
10th Dec 20212:20 pmRNSAcquisition
10th Dec 20217:00 amRNSPirum Systems secures new investor Hg
9th Dec 20215:40 pmRNSIssue of Equity
8th Dec 20215:31 pmRNSIssue of Equity
7th Dec 20215:18 pmRNSIssue of Equity
6th Dec 20215:43 pmRNSIssue of Equity
3rd Dec 20215:31 pmRNSIssue of Equity
2nd Dec 20215:30 pmRNSIssue of Equity
1st Dec 20215:44 pmRNSIssue of Equity
1st Dec 20217:00 amRNSTotal Voting Rights
29th Nov 20215:09 pmRNSIssue of Equity
29th Nov 20213:31 pmRNSHolding(s) in Company
26th Nov 20215:47 pmRNSIssue of Equity
26th Nov 20219:38 amRNSHolding(s) in Company
25th Nov 20215:20 pmRNSIssue of Equity
24th Nov 20215:43 pmRNSIssue of Equity
22nd Nov 20215:21 pmRNSIssue of Equity
19th Nov 20215:40 pmRNSIssue of Equity
18th Nov 20215:22 pmRNSIssue of Equity
17th Nov 20215:52 pmRNSIssue of Equity
17th Nov 20219:00 amRNSRevalize announces minority investment from Hg
15th Nov 20216:01 pmRNSIssue of Equity
15th Nov 20215:42 pmRNSBlock listing Interim Review
15th Nov 20212:01 pmRNSBlock Listing Application
15th Nov 20217:00 amRNSQ3 Report to 30 September 2021
5th Nov 20217:00 amRNSLitera secures further investment from Hg
1st Oct 202112:50 pmRNSTotal Voting Rights
30th Sep 20215:19 pmRNSIssue of Equity
29th Sep 20215:14 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.